fexinidazole
Commercial- Indications
- Human African trypanosomiasis
Company intelligence / Profile preview
Viruj Group is an India-based API manufacturer with global reach specializing in small molecule development from lab scale to commercial production. It has supported over 10 commercial molecules and more than 5 pre-clinical/clinical candidates recently. The group is known for process innovation including non-infringing routes and novel polymorphs targeting regulated markets. Clinical results are not directly reported as the company operates as a CDMO/CRO partner rather than developing proprietary therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viruj Group.